To order this detailed 800+ page report, please visit https://www.rootsanalysis.com/reports/view_document/prefilled-syringes-market/284.html
Key Inclusions
§
An overview of the
current market landscape of companies engaged in manufacturing prefilled
syringes, providing information on year of establishment, company size,
geographical location of the headquarters and manufacturing facilities, type of
material used (glass and plastic), number of barrel chambers (single chamber
and dual chamber), type of needle system (fixed needle system, luer lock and
luer cone) and syringe volume.
§
An overview of the
current market landscape of companies that are developing drugs in combination
with prefilled syringes, featuring information on year of establishment,
company size, geographical location of the developers, target therapeutic area,
phases of development, type of drug molecule, route of administration, approval
year (for marketed products), dosage details (for marketed products) and other
approved dosage forms (for marketed products).
§
A detailed
competitiveness analysis of the various prefilled syringes that we came across,
taking into consideration the supplier power (based on the employee size of
developer / manufacturer and their respective annual revenues) and key product
specifications, such as number of chambers in the barrel, number of needle
systems, volume of the barrel, technological advancement / user-friendliness
and other distinguishing features.
§
A list of marketed
drugs / therapies and pipeline candidates that are likely to be developed in
combination with prefilled syringes in the near future, shortlisted based on an
in-depth analysis that takes into consideration various relevant parameters,
such as route of administration, type of drug molecule, target indications,
other available dosage forms (for approved drugs) and historical annual sales
information (for approved drugs).
§
An analysis
presenting potential strategic partners (primarily drug developers) for
prefilled syringe manufacturers (with regard to likely collaboration
opportunities for combination product development) based on different
parameters, such as pipeline strength, target therapeutic indication(s) and
developer strength.
§
An analysis of the
various prefilled syringe combination product-related initiatives of big pharma
players, based on parameters, such as current adoption (based on number of
approved and under development prefilled syringe combination products) and likely
future adoption (based on potential injectable product candidates in the
pipeline that are likely to be delivered via prefilled syringes), target
therapeutic area(s) and type of drug molecule.
§
A review of the
landscape of contract fill / finish services providers that offer services for
prefilled syringes, featuring a list of active (large-sized) service providers
and analysis based on a number of relevant parameters, such as year of
establishment, company size, scale of operation (preclinical, clinical and
commercial), type of drug molecule (biologics and small molecules), and
geographical location of the service provider.
§
A detailed discussion
on various safety features (add-on and integrated devices) installed in recent
versions of prefilled syringes and the companies involved in developing and
manufacturing such solutions.
§
An informative
summary of various guidelines established and issued by major regulatory bodies
for the approval of prefilled syringes, across different countries /
geographical regions.
§
Brief discussions of
currently available specialty syringes, which include prefilled flush syringes,
prefilled diluent syringe systems and prefilled contrast agent delivery
systems.
§
A case study on
companies that are engaged in the manufacturing of autoinjectors, featuring
brief profiles of key players in this domain; each profile includes an overview
of the firm, and information on its respective product portfolio.
§
Elaborate profiles of
prominent prefilled syringe manufacturers engaged in this domain, featuring a
brief overview of the company, its financial information (if available),
information on product portfolio, recent developments and an informed future
outlook.
The report also features the likely
distribution of the current and forecasted opportunity across important market
segments, mentioned below:
§
Autoimmune disorders
§
Infectious diseases
§
Neurological disorders
§
Blood disorders
§
Oncological disorders
§
Psychiatric disorders
§
Respiratory disorders
§
Cardiovascular disorders
§
Metabolic disorders
§
Ophthalmic diseases
§
Orthopedic disorders
§
Others
§
Specialty syringes
- Type
of syringe barrel material
§
Glass
§
Plastic
- Number
of barrel chambers
§
Single chamber
§
Dual chamber
§
North America
§
Europe
§
Latin America
§
Asia Pacific
§
Middle East and Africa
To request sample pages, please visit this link
Key Questions Answered
§
Who are the key players engaged in the manufacturing of
prefilled syringes, across the globe?
§
What are the prevalent trends within the prefilled syringes
market?
§ What
are the current regulatory requirements for securing marketing authorizations for
prefilled syringe combination products, across different countries?
§
What technological advances have taken place in the prefilled
syringes market?
§ What
are the key growth drivers within the prefilled syringes market?
§
Who are the key contract service providers in this domain?
§
How is the current and future market opportunity likely to
be distributed across key market segments?
You may also be interested in the following titles:
1.
Global Autoinjectors
Market (3rd Edition), 2020-2030
2.
Novel Vaccine
Delivery Devices Market, 2019-2030
3.
Microneedles and Needle-Free Injection Systems / Jet
Injectors (Devices based on Spring, Gas and Other Mechanisms) Market, 2019-2030
4.
Medical Device Labels Manufacturing Market, 2019 - 2030
Contact Us
Gaurav Chaudhary
+1 (415) 800 3415
gaurav.chaudhary@rootsanalysis.com
